CANAGLIFLOZIN

CANAGLIFLOZIN was reported 29868 times

CANAGLIFLOZIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 METATARSAL EXCISION 102 0.7286
1 LIMB AMPUTATION 269 0.6776
2 DIABETIC FOOT INFECTION 834 0.5886
3 OSTEOMYELITIS ACUTE 283 0.5221
4 MALIGNANT MEDIASTINAL NEOPLASM 57 0.5182
5 DIABETIC NEUROPATHIC ULCER 11 0.4400
6 TOE AMPUTATION 2196 0.4320
7 FOOT AMPUTATION 582 0.3997
8 GAS GANGRENE 117 0.3411
9 GENITAL INFECTION FUNGAL 281 0.3402
10 DIABETIC ULCER 225 0.3156
11 AMPUTATION 325 0.2604
12 DIABETIC FOOT 788 0.2572
13 ISCHAEMIC SKIN ULCER 19 0.2043
14 LEG AMPUTATION 792 0.1920
15 OSTEOMYELITIS CHRONIC 114 0.1842
16 GANGRENE 1086 0.1800
17 DRY GANGRENE 114 0.1795
18 NEUROPATHIC ARTHROPATHY 114 0.1762
19 DIABETIC GANGRENE 50 0.1761
20 DIABETIC KETOACIDOSIS 3441 0.1431
21 CELLULITIS OF MALE EXTERNAL GENITAL ORGAN 16 0.1429
22 OSTEOMYELITIS 2165 0.1194
23 BALANOPOSTHITIS 92 0.1119
24 URINE OUTPUT INCREASED 239 0.0915
25 CELLULITIS GANGRENOUS 18 0.0914
26 KETOACIDOSIS 645 0.0861
27 GENITAL INFECTION 28 0.0848
28 EUGLYCAEMIC DIABETIC KETOACIDOSIS 296 0.0716
29 STAPHYLOCOCCAL OSTEOMYELITIS 13 0.0699
30 VASCULAR STENOSIS 20 0.0581
31 JOINT ANKYLOSIS 33 0.0581
32 URINE KETONE BODY 9 0.0552
33 EXTREMITY NECROSIS 95 0.0544
34 KETONURIA 41 0.0504
35 BLOOD KETONE BODY 17 0.0490
36 URINARY TRACT INFECTION FUNGAL 28 0.0488
37 URINE KETONE BODY PRESENT 77 0.0488
38 MUSCULOSKELETAL TOXICITY 9 0.0484
39 ACETONAEMIA 12 0.0476
40 NECROTISING SOFT TISSUE INFECTION 11 0.0476
41 PENILE INFECTION 9 0.0464
42 PENILE ERYTHEMA 17 0.0453
43 GLUCOSE URINE PRESENT 57 0.0448
44 DIABETIC KETOSIS 17 0.0447
45 NECROTISING OESOPHAGITIS 22 0.0441
46 FUNGAL INFECTION 1447 0.0434
47 VULVOVAGINITIS 11 0.0374
48 SCROTAL ABSCESS 14 0.0370
49 KETOSIS 39 0.0359
50 BLOOD KETONE BODY INCREASED 28 0.0359
51 BONE CYST 33 0.0352
52 NECROTISING FASCIITIS 124 0.0351
53 FASCIITIS 23 0.0351
54 VULVOVAGINAL MYCOTIC INFECTION 126 0.0320
55 CREATININE RENAL CLEARANCE INCREASED 23 0.0307
56 VULVITIS 10 0.0305
57 NECROSIS ISCHAEMIC 14 0.0304
58 GENITAL ABSCESS 12 0.0297
59 ABSCESS LIMB 125 0.0293
60 MYOPATHY TOXIC 18 0.0291
61 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 15 0.0287
62 PHIMOSIS 21 0.0285
63 GENITOURINARY TRACT INFECTION 8 0.0284
64 CEREBRAL FUNGAL INFECTION 8 0.0283
65 MICROALBUMINURIA 21 0.0278
66 BONE OPERATION 18 0.0273
67 FINGER AMPUTATION 20 0.0272
68 ABNORMAL LOSS OF WEIGHT 185 0.0271
69 PERIPHERAL ISCHAEMIA 109 0.0267
70 DISABILITY ASSESSMENT SCALE SCORE INCREASED 8 0.0261
71 THERAPEUTIC RESPONSE INCREASED 24 0.0255
72 GLYCOSURIA 33 0.0244
73 PERINEAL ABSCESS 11 0.0244
74 VULVAL ABSCESS 10 0.0243
75 BLOOD IMMUNOGLOBULIN E INCREASED 57 0.0235
76 GLYCOSYLATED HAEMOGLOBIN DECREASED 37 0.0230
77 VULVOVAGINAL CANDIDIASIS 30 0.0222
78 SKIN ULCER 572 0.0221
79 PRURITUS GENITAL 52 0.0221
80 DIABETIC GASTROPARESIS 8 0.0218
81 GENITAL RASH 31 0.0217
82 GROIN ABSCESS 25 0.0212
83 ALBUMIN URINE PRESENT 8 0.0211
84 WOUND NECROSIS 10 0.0208
85 BLOOD URIC ACID DECREASED 10 0.0206
86 CELLULITIS 1036 0.0205
87 GLYCOSYLATED HAEMOGLOBIN INCREASED 515 0.0204
88 GLOMERULAR FILTRATION RATE DECREASED 244 0.0198
89 SOFT TISSUE NECROSIS 13 0.0189
90 ANION GAP INCREASED 24 0.0179
91 CREATININE RENAL CLEARANCE ABNORMAL 8 0.0173
92 ALANINE AMINOTRANSFERASE ABNORMAL 36 0.0171
93 VULVOVAGINAL PRURITUS 86 0.0170
94 OSTEOLYSIS 34 0.0166
95 SOFT TISSUE INJURY 12 0.0159
96 FULL BLOOD COUNT ABNORMAL 167 0.0158
97 DEBRIDEMENT 12 0.0156
98 UROSEPSIS 143 0.0155
99 HEPATIC FIBROSIS 51 0.0148
100 INFECTED SKIN ULCER 28 0.0148
101 HYPERTROPHY 8 0.0147
102 RENAL ABSCESS 12 0.0147
103 METABOLIC ENCEPHALOPATHY 44 0.0146
104 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 33 0.0143
105 SKIN INJURY 47 0.0142
106 ARTHRITIS BACTERIAL 57 0.0139
107 NECROSIS 74 0.0133
108 ACUTE KIDNEY INJURY 2008 0.0131
109 POLYURIA 106 0.0129
110 MICTURITION DISORDER 44 0.0127
111 STEROID DIABETES 19 0.0127
112 PERIRECTAL ABSCESS 14 0.0126
113 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 14 0.0126
114 PROSTATITIS 38 0.0125
115 HEMIANOPIA HOMONYMOUS 9 0.0123
116 METABOLIC ACIDOSIS 384 0.0120
117 POLYDIPSIA 47 0.0119
118 BLOOD PRESSURE DIASTOLIC ABNORMAL 30 0.0118
119 POLLAKIURIA 491 0.0118
120 THIRST 209 0.0117
121 BLOOD BICARBONATE DECREASED 22 0.0116
122 GENITAL BURNING SENSATION 10 0.0115
123 EXTRADURAL ABSCESS 9 0.0115
124 VAGINAL INFECTION 54 0.0115
125 BRONCHIECTASIS 77 0.0114
126 PYELONEPHRITIS 99 0.0114
127 GLYCOSYLATED HAEMOGLOBIN ABNORMAL 13 0.0109
128 DIABETES MELLITUS INADEQUATE CONTROL 191 0.0108
129 BREAST DISORDER 22 0.0108
130 DRUG PRESCRIBING ERROR 205 0.0107
131 ACIDOSIS 77 0.0101
132 WOUND DEHISCENCE 34 0.0101
133 FUNGAL SKIN INFECTION 40 0.0099
134 LOCALISED INFECTION 235 0.0097
135 PYELONEPHRITIS ACUTE 19 0.0097
136 CEREBRAL VENOUS SINUS THROMBOSIS 8 0.0095
137 HYPOVOLAEMIA 55 0.0094
138 VAGINAL DISORDER 9 0.0094
139 BONE EROSION 33 0.0093
140 BLOOD GLUCOSE FLUCTUATION 101 0.0092
141 POLYCYTHAEMIA 19 0.0092
142 METABOLIC SURGERY 10 0.0088
143 MYCOBACTERIAL INFECTION 15 0.0087
144 PANCREATITIS NECROTISING 18 0.0078
145 RECTAL ABSCESS 13 0.0077
146 HYPERGLYCAEMIA 270 0.0074
147 POSTOPERATIVE WOUND INFECTION 50 0.0074
148 PENILE PAIN 22 0.0072
149 DIABETIC NEUROPATHY 34 0.0069
150 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 28 0.0069
151 RESPIRATORY ALKALOSIS 11 0.0068
152 FLANK PAIN 63 0.0067
153 PANCREATITIS 348 0.0066
154 BLOOD GLUCOSE INCREASED 1235 0.0065
155 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 25 0.0065
156 RENAL PAIN 69 0.0065
157 LOWER RESPIRATORY TRACT CONGESTION 11 0.0065
158 HYPERKALAEMIA 226 0.0064
159 NOCTURIA 78 0.0064
160 INTENSIVE CARE 9 0.0063
161 TYPE 2 DIABETES MELLITUS 211 0.0063
162 INSULIN RESISTANCE 13 0.0062
163 BLOOD PRESSURE SYSTOLIC ABNORMAL 15 0.0061
164 PERIPHERAL VASCULAR DISORDER 31 0.0060
165 URINARY TRACT INFECTION 1019 0.0060
166 BLOOD GLUCOSE ABNORMAL 110 0.0059
167 TYMPANIC MEMBRANE PERFORATION 10 0.0059
168 BLOOD GLUCOSE DECREASED 282 0.0059
169 BLOOD PH DECREASED 10 0.0058
170 BLOOD PRESSURE DIASTOLIC DECREASED 43 0.0058
171 HYPOGLYCAEMIA 277 0.0057
172 PANCREATITIS ACUTE 127 0.0056
173 C-REACTIVE PROTEIN ABNORMAL 36 0.0056
174 URINE ODOUR ABNORMAL 33 0.0056
175 SKIN NECROSIS 29 0.0056
176 RENAL TUBULAR ACIDOSIS 12 0.0055
177 DEHYDRATION 732 0.0055
178 ORAL FUNGAL INFECTION 15 0.0055
179 GENITAL PAIN 8 0.0054
180 DIABETIC COMA 15 0.0054
181 RENAL FAILURE 711 0.0053
182 VITAMIN B12 DECREASED 15 0.0052
183 LOW DENSITY LIPOPROTEIN INCREASED 40 0.0052
184 URINARY TRACT INFECTION BACTERIAL 13 0.0051
185 SEPSIS 573 0.0051
186 HEPATOSPLENOMEGALY 13 0.0051
187 LACTIC ACIDOSIS 164 0.0051
188 IMPAIRED HEALING 163 0.0050
189 FOOT DEFORMITY 55 0.0050
190 VARICES OESOPHAGEAL 15 0.0050
191 DYSURIA 181 0.0049
192 INJECTION SITE NODULE 54 0.0049
193 TRIGGER FINGER 20 0.0049
194 WEIGHT DECREASED 1349 0.0048
195 BLOOD POTASSIUM INCREASED 78 0.0048
196 GASTROINTESTINAL INFECTION 43 0.0048
197 ADVERSE EVENT 440 0.0048
198 INTERCEPTED MEDICATION ERROR 22 0.0047
199 URINE ANALYSIS ABNORMAL 14 0.0047
200 HEPATIC CIRRHOSIS 87 0.0046
201 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 33 0.0046
202 HAEMOGLOBIN INCREASED 21 0.0046
203 PRODUCT LABEL ISSUE 31 0.0046
204 TREATMENT NONCOMPLIANCE 250 0.0046
205 DIABETIC NEPHROPATHY 10 0.0045
206 INTENTIONAL DEVICE MISUSE 20 0.0045
207 VULVOVAGINAL DISCOMFORT 20 0.0045
208 BLOOD CREATININE DECREASED 14 0.0045
209 BLOOD PRESSURE SYSTOLIC DECREASED 20 0.0044
210 BLADDER SPASM 8 0.0043
211 ANAL ABSCESS 23 0.0043
212 IMPAIRED GASTRIC EMPTYING 58 0.0043
213 PANCREATIC CARCINOMA METASTATIC 12 0.0042
214 GASTROENTERITIS 61 0.0042
215 RENAL INJURY 122 0.0041
216 WOUND COMPLICATION 14 0.0041
217 MICTURITION URGENCY 46 0.0040
218 VULVOVAGINAL DRYNESS 13 0.0040
219 CREATININE RENAL CLEARANCE DECREASED 16 0.0040
220 GASTROINTESTINAL HYPOMOTILITY 9 0.0040
221 BLOOD LACTIC ACID INCREASED 21 0.0040
222 HYPOVOLAEMIC SHOCK 19 0.0040
223 HAEMORRHAGE URINARY TRACT 10 0.0039
224 DIABETIC COMPLICATION 10 0.0039
225 STAPHYLOCOCCAL BACTERAEMIA 17 0.0039
226 BLOOD URINE PRESENT 74 0.0039
227 HEPATIC STEATOSIS 72 0.0039
228 BODY TEMPERATURE FLUCTUATION 8 0.0038
229 ESCHERICHIA BACTERAEMIA 9 0.0038
230 DIZZINESS POSTURAL 37 0.0038
231 HYPERNATRAEMIA 19 0.0038
232 PROTEIN URINE PRESENT 19 0.0038
233 INGROWING NAIL 9 0.0038
234 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 271 0.0038
235 HYPERSENSITIVITY VASCULITIS 10 0.0038
236 PANCREATITIS CHRONIC 9 0.0038
237 URINE FLOW DECREASED 9 0.0038
238 URINE ABNORMALITY 17 0.0037
239 BLOOD TRIGLYCERIDES INCREASED 66 0.0037
240 HUNGER 52 0.0037
241 WEIGHT FLUCTUATION 39 0.0037
242 FINGER DEFORMITY 18 0.0037
243 GASTRIC BYPASS 8 0.0037
244 CYSTITIS 117 0.0037
245 CANDIDA INFECTION 62 0.0037
246 HYDRONEPHROSIS 27 0.0036
247 BLOOD CREATININE INCREASED 234 0.0036
248 BLOOD COUNT ABNORMAL 54 0.0036
249 URINARY TRACT DISORDER 16 0.0035
250 FOOD POISONING 19 0.0035
251 LIPASE INCREASED 27 0.0035
252 HAEMATOCRIT INCREASED 8 0.0035
253 KIDNEY INFECTION 68 0.0035
254 MULTIPLE ALLERGIES 27 0.0034
255 FOOD CRAVING 18 0.0034
256 ORAL CANDIDIASIS 45 0.0034
257 WOUND INFECTION 37 0.0034
258 SUBCUTANEOUS ABSCESS 16 0.0033
259 INJECTION SITE EXTRAVASATION 41 0.0033
260 STAPHYLOCOCCAL SEPSIS 16 0.0032
261 BLADDER PAIN 10 0.0031
262 VULVOVAGINAL BURNING SENSATION 19 0.0031
263 DRUG DOSE OMISSION 514 0.0031
264 ESCHERICHIA SEPSIS 9 0.0031
265 DIABETES MELLITUS 236 0.0031
266 HYPERKERATOSIS 17 0.0031
267 ACUTE RESPIRATORY FAILURE 59 0.0031
268 RENAL TUBULAR NECROSIS 30 0.0031
269 HAEMATURIA 104 0.0030
270 FOOT OPERATION 15 0.0030
271 ULCER 48 0.0030
272 NEPHROLITHIASIS 138 0.0030
273 TOXIC ENCEPHALOPATHY 15 0.0030
274 INCONTINENCE 31 0.0029
275 RENAL IMPAIRMENT 241 0.0029
276 WOUND 80 0.0029
277 ENDOTRACHEAL INTUBATION 8 0.0029
278 ERUCTATION 55 0.0028
279 FACIAL PARESIS 10 0.0028
280 GASTROOESOPHAGEAL REFLUX DISEASE 226 0.0028
281 NEPHROGENIC ANAEMIA 13 0.0028
282 NEPHROPATHY 26 0.0028
283 OESOPHAGEAL CANDIDIASIS 11 0.0028
284 SKIN ABRASION 13 0.0027
285 ACUTE MYOCARDIAL INFARCTION 81 0.0027
286 BLADDER DISORDER 27 0.0027
287 SEPTIC SHOCK 118 0.0027
288 BLOOD CREATINE INCREASED 12 0.0027
289 ASTHMA 301 0.0027
290 INJECTION SITE MASS 98 0.0026
291 DIABETIC RETINOPATHY 9 0.0026
292 PROCTALGIA 17 0.0026
293 ABSCESS 42 0.0026
294 BLOOD PRESSURE FLUCTUATION 63 0.0026
295 NODULE 34 0.0026
296 HAND DEFORMITY 34 0.0026
297 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 44 0.0026
298 METABOLIC DISORDER 15 0.0026
299 HYPOPHAGIA 65 0.0025
300 BODY TEMPERATURE DECREASED 25 0.0025
301 SUSPECTED COUNTERFEIT PRODUCT 10 0.0025
302 ORTHOSTATIC HYPOTENSION 44 0.0025
303 HYPERPHAGIA 10 0.0025
304 HAEMORRHAGIC ANAEMIA 11 0.0025
305 VULVOVAGINAL PAIN 12 0.0025
306 BACTERIAL SEPSIS 8 0.0025
307 DECUBITUS ULCER 20 0.0025
308 AMYLASE INCREASED 9 0.0024
309 PANCREATIC DISORDER 12 0.0024
310 TENDERNESS 25 0.0024
311 RASH GENERALISED 62 0.0024
312 ESCHERICHIA URINARY TRACT INFECTION 10 0.0024
313 PHARYNGEAL OEDEMA 36 0.0023
314 BENIGN PROSTATIC HYPERPLASIA 12 0.0023
315 BLOOD CREATININE ABNORMAL 8 0.0023
316 URINARY INCONTINENCE 68 0.0023
317 CHOLECYSTITIS ACUTE 13 0.0023
318 PROSTATOMEGALY 9 0.0023
319 SKIN ODOUR ABNORMAL 9 0.0023
320 ONYCHOMYCOSIS 10 0.0023
321 RENAL DISORDER 106 0.0023
322 BLOOD UREA INCREASED 38 0.0023
323 JAUNDICE CHOLESTATIC 8 0.0023
324 MYOCARDIAL INFARCTION 394 0.0023
325 RESPIRATORY RATE INCREASED 20 0.0023
326 PRE-EXISTING CONDITION IMPROVED 14 0.0022
327 LIGAMENT SPRAIN 22 0.0022
328 NEPHROTIC SYNDROME 15 0.0022
329 NONSPECIFIC REACTION 12 0.0022
330 PRODUCT USE ISSUE 410 0.0022
331 BLOOD CHOLESTEROL ABNORMAL 10 0.0022
332 FREEZING PHENOMENON 8 0.0022
333 RENAL FUNCTION TEST ABNORMAL 10 0.0022
334 HALLUCINATION, AUDITORY 34 0.0021
335 OBESITY 34 0.0021
336 THERAPEUTIC RESPONSE UNEXPECTED 95 0.0021
337 LEUKOCYTOSIS 38 0.0021
338 ATRIOVENTRICULAR BLOCK COMPLETE 14 0.0021
339 WHEEZING 124 0.0021
340 BLOOD PRESSURE SYSTOLIC INCREASED 40 0.0020
341 CHRONIC KIDNEY DISEASE 155 0.0020
342 HYPERCHLORHYDRIA 12 0.0020
343 HYPERCALCAEMIA 25 0.0020
344 BACTERAEMIA 24 0.0020
345 HEPATIC ENZYME ABNORMAL 10 0.0020
346 STAPHYLOCOCCAL INFECTION 66 0.0020
347 PSORIATIC ARTHROPATHY 81 0.0020
348 SENSORY LOSS 16 0.0020
349 OBSTRUCTIVE AIRWAYS DISORDER 22 0.0020
350 DRUG LEVEL ABOVE THERAPEUTIC 9 0.0020
351 BLOOD PRESSURE DIASTOLIC INCREASED 9 0.0019
352 CEREBROVASCULAR ACCIDENT 326 0.0019
353 HEPATOCELLULAR INJURY 27 0.0019
354 PHOTOPSIA 12 0.0019
355 FURUNCLE 15 0.0019
356 PRODUCT PRESCRIBING ERROR 45 0.0019
357 LARGE INTESTINE POLYP 13 0.0019
358 OVERWEIGHT 10 0.0019
359 DRY MOUTH 151 0.0019
360 PEMPHIGOID 14 0.0019
361 BLOOD PRESSURE DECREASED 123 0.0018
362 FOOT FRACTURE 35 0.0018
363 CHAPPED LIPS 8 0.0018
364 CEREBRAL INFARCTION 45 0.0018
365 POLYP 12 0.0018
366 ERECTILE DYSFUNCTION 47 0.0018
367 URINE OUTPUT DECREASED 16 0.0018
368 SYNOVITIS 33 0.0018
369 TRANSAMINASES INCREASED 40 0.0018
370 WRONG TECHNIQUE IN DRUG USAGE PROCESS 65 0.0018
371 MASS 25 0.0018
372 ANGIOPATHY 10 0.0018
373 FLATULENCE 100 0.0018
374 PRURITUS GENERALISED 38 0.0018
375 EAR DISORDER 8 0.0017
376 ADVERSE DRUG REACTION 156 0.0017
377 INCORRECT DOSE ADMINISTERED 396 0.0017
378 CARDIOVASCULAR DISORDER 44 0.0017
379 BLOOD POTASSIUM DECREASED 52 0.0017
380 PARTIAL SEIZURES 9 0.0017
381 HYPERTRIGLYCERIDAEMIA 10 0.0017
382 DIZZINESS 847 0.0017
383 DRUG-INDUCED LIVER INJURY 53 0.0017
384 MEDICATION RESIDUE PRESENT 8 0.0017
385 GOUT 30 0.0017
386 APPETITE DISORDER 11 0.0017
387 MUSCLE ATROPHY 21 0.0017
388 ARTERIAL OCCLUSIVE DISEASE 13 0.0017
389 INJECTION SITE HAEMORRHAGE 132 0.0017
390 HYPOACUSIS 71 0.0016
391 COLD SWEAT 29 0.0016
392 FACIAL PARALYSIS 14 0.0016
393 VITAMIN D DECREASED 14 0.0016
394 PROSTATIC DISORDER 9 0.0016
395 BLOOD CHOLESTEROL INCREASED 76 0.0016
396 HEART RATE ABNORMAL 9 0.0016
397 INFLAMMATORY MARKER INCREASED 8 0.0016
398 INJURY 113 0.0016
399 GASTROENTERITIS VIRAL 29 0.0016
400 MUSCLE DISORDER 13 0.0016
401 POST PROCEDURAL INFECTION 13 0.0016
402 BLOOD CALCIUM INCREASED 14 0.0016
403 ARTERIOSCLEROSIS 15 0.0016
404 UNEVALUABLE EVENT 120 0.0016
405 RHABDOMYOLYSIS 66 0.0016
406 PRODUCT PACKAGING ISSUE 15 0.0016
407 DYSLIPIDAEMIA 8 0.0016
408 FEELING JITTERY 30 0.0016
409 SLEEP APNOEA SYNDROME 30 0.0016
410 CARPAL TUNNEL SYNDROME 22 0.0016
411 PRESYNCOPE 38 0.0016
412 MOUTH SWELLING 9 0.0016
413 CHROMATURIA 35 0.0015
414 NASAL CONGESTION 91 0.0015
415 TOOTH FRACTURE 17 0.0015
416 HYPOTHYROIDISM 49 0.0015
417 RHINORRHOEA 99 0.0015
418 PRODUCT DOSE OMISSION 99 0.0015
419 C-REACTIVE PROTEIN INCREASED 55 0.0015
420 RENAL CYST 12 0.0015
421 HYPOKALAEMIA 69 0.0015
422 HEART RATE INCREASED 147 0.0015
423 END STAGE RENAL DISEASE 27 0.0015
424 DIALYSIS 21 0.0015
425 FRACTURE 28 0.0015
426 LIMB INJURY 40 0.0015
427 BACK INJURY 16 0.0015
428 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 10 0.0015
429 HYPOTENSION 295 0.0015
430 DRUG DIVERSION 9 0.0015
431 HAIR DISORDER 12 0.0015
432 INTESTINAL ISCHAEMIA 8 0.0015
433 JOINT EFFUSION 10 0.0014
434 UPPER RESPIRATORY TRACT INFECTION 67 0.0014
435 INJECTION SITE INJURY 8 0.0014
436 SKIN DISCOLOURATION 66 0.0014
437 INJECTION SITE DISCOMFORT 15 0.0014
438 ENCEPHALOPATHY 35 0.0014
439 THERAPY CHANGE 14 0.0014
440 INCREASED APPETITE 27 0.0014
441 DYSPEPSIA 139 0.0014
442 LIP SWELLING 47 0.0014
443 SINUS CONGESTION 19 0.0014
444 OXYGEN SATURATION DECREASED 78 0.0014
445 PERIPHERAL COLDNESS 19 0.0014
446 VAGINAL DISCHARGE 14 0.0014
447 ABDOMINAL DISCOMFORT 232 0.0014
448 VOMITING 647 0.0014
449 FAECES SOFT 10 0.0014
450 DECREASED APPETITE 317 0.0014
451 ANGINA PECTORIS 39 0.0014
452 MUSCLE TIGHTNESS 22 0.0014
453 FIBROMYALGIA 33 0.0014
454 HYPOPHOSPHATAEMIA 10 0.0014
455 BACK DISORDER 22 0.0014
456 POOR VENOUS ACCESS 14 0.0014
457 URINARY RETENTION 45 0.0013
458 GALLBLADDER DISORDER 24 0.0013
459 HYPERHIDROSIS 173 0.0013
460 BLISTER 75 0.0013
461 INCORRECT DOSE ADMINISTERED BY DEVICE 35 0.0013
462 FREQUENT BOWEL MOVEMENTS 36 0.0013
463 UNDERDOSE 97 0.0013
464 THERAPY CESSATION 68 0.0013
465 ACCIDENTAL UNDERDOSE 19 0.0013
466 CORONARY ARTERY OCCLUSION 18 0.0013
467 BODY HEIGHT DECREASED 14 0.0013
468 PROSTATIC SPECIFIC ANTIGEN INCREASED 18 0.0013
469 ABDOMINAL PAIN 303 0.0013
470 IRON DEFICIENCY ANAEMIA 12 0.0013
471 NAUSEA 1026 0.0013
472 ISCHAEMIC STROKE 23 0.0013
473 PANCREATIC CARCINOMA 37 0.0013
474 MUSCLE SPASMS 235 0.0013
475 DRY THROAT 13 0.0013
476 BACK PAIN 297 0.0013
477 LOWER RESPIRATORY TRACT INFECTION 58 0.0013
478 BLOOD MAGNESIUM DECREASED 11 0.0013
479 LETHARGY 73 0.0013
480 DENTAL CARIES 14 0.0013
481 RED BLOOD CELL SEDIMENTATION RATE INCREASED 14 0.0013
482 PROTEINURIA 24 0.0013
483 GROIN PAIN 11 0.0013
484 SENSORY DISTURBANCE 20 0.0012
485 ROTATOR CUFF SYNDROME 16 0.0012
486 DRUG DISPENSING ERROR 19 0.0012
487 CARDIAC FLUTTER 8 0.0012
488 FACIAL PAIN 11 0.0012
489 THERAPEUTIC PRODUCT EFFECT DECREASED 55 0.0012
490 TUBULOINTERSTITIAL NEPHRITIS 23 0.0012
491 WEIGHT INCREASED 274 0.0012
492 DIARRHOEA 789 0.0012
493 EATING DISORDER 26 0.0012
494 BLINDNESS TRANSIENT 9 0.0012
495 PSYCHIATRIC SYMPTOM 9 0.0012
496 GASTROINTESTINAL DISORDER 109 0.0012
497 ESCHERICHIA INFECTION 10 0.0012
498 MOVEMENT DISORDER 39 0.0012
499 RASH 528 0.0012
500 ABDOMINAL PAIN UPPER 249 0.0012
501 BLOOD PRESSURE ABNORMAL 24 0.0012
502 ELECTROLYTE IMBALANCE 14 0.0012
503 SKIN DISORDER 40 0.0012
504 DYSSTASIA 35 0.0012
505 RETINAL DETACHMENT 11 0.0012
506 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 242 0.0012
507 SCIATICA 19 0.0012
508 BLOOD PRESSURE INCREASED 182 0.0012
509 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 57 0.0012
510 TOOTH ABSCESS 12 0.0012
511 MIDDLE INSOMNIA 22 0.0012
512 FEELING ABNORMAL 282 0.0012
513 CATARACT 70 0.0012
514 ABASIA 29 0.0012
515 LACERATION 11 0.0012
516 CONSTIPATION 255 0.0012
517 OFF LABEL USE 1021 0.0012
518 DISABILITY 23 0.0012
519 SKIN INFECTION 13 0.0012
520 MENTAL IMPAIRMENT 28 0.0012
521 HYSTERECTOMY 10 0.0012
522 UPPER LIMB FRACTURE 23 0.0012
523 SWOLLEN TONGUE 36 0.0012
524 ARTHROPATHY 64 0.0012
525 MALAISE 505 0.0012
526 PHOTOSENSITIVITY REACTION 19 0.0011
527 BLOOD CREATINE PHOSPHOKINASE INCREASED 33 0.0011
528 EXTRASYSTOLES 8 0.0011
529 DEFAECATION URGENCY 8 0.0011
530 BEDRIDDEN 15 0.0011
531 GASTRITIS 30 0.0011
532 BLINDNESS UNILATERAL 16 0.0011
533 NEEDLE ISSUE 33 0.0011
534 SHOCK 26 0.0011
535 DEVICE LEAKAGE 49 0.0011
536 EYE SWELLING 42 0.0011
537 SURGERY 66 0.0011
538 IMPAIRED WORK ABILITY 24 0.0011
539 HAIR TEXTURE ABNORMAL 15 0.0011
540 HYPERSOMNIA 32 0.0011
541 STENT PLACEMENT 9 0.0011
542 DERMATITIS ALLERGIC 14 0.0011
543 RESPIRATORY FAILURE 81 0.0011
544 PERIPHERAL SWELLING 171 0.0011
545 GASTRIC DISORDER 38 0.0011
546 OROPHARYNGEAL DISCOMFORT 10 0.0011
547 LIVER DISORDER 49 0.0011
548 GASTRIC ULCER 21 0.0011
549 TRANSIENT ISCHAEMIC ATTACK 37 0.0011
550 CHOLECYSTITIS 13 0.0011
551 GASTROINTESTINAL PAIN 12 0.0011
552 DYSGEUSIA 81 0.0011
553 ACUTE CORONARY SYNDROME 9 0.0011
554 URTICARIA 182 0.0011
555 FEEDING DISORDER 22 0.0011
556 RETCHING 23 0.0011
557 INTENTIONAL PRODUCT USE ISSUE 94 0.0011
558 INFECTION 155 0.0011
559 SYNCOPE 107 0.0011
560 ASTHENIA 401 0.0011
561 HAEMATEMESIS 27 0.0011
562 ACTIVITIES OF DAILY LIVING IMPAIRED 21 0.0011
563 SEASONAL ALLERGY 15 0.0011
564 SMALL INTESTINAL OBSTRUCTION 13 0.0011
565 IMPAIRED DRIVING ABILITY 12 0.0011
566 SPINAL OPERATION 13 0.0011
567 SCAR 18 0.0011
568 PRODUCT ODOUR ABNORMAL 11 0.0010
569 CARDIAC OPERATION 9 0.0010
570 HAIR COLOUR CHANGES 13 0.0010
571 SCRATCH 11 0.0010
572 HALLUCINATION, VISUAL 22 0.0010
573 SECRETION DISCHARGE 13 0.0010
574 MADAROSIS 12 0.0010
575 NEUROPATHY PERIPHERAL 98 0.0010
576 INTENTIONAL PRODUCT MISUSE 90 0.0010
577 ROAD TRAFFIC ACCIDENT 43 0.0010
578 SPINAL OSTEOARTHRITIS 9 0.0010
579 RIB FRACTURE 21 0.0010
580 ATRIAL FIBRILLATION 99 0.0010
581 KNEE OPERATION 10 0.0010
582 PALPITATIONS 119 0.0010
583 WRONG DRUG ADMINISTERED 9 0.0010
584 BLOOD SODIUM DECREASED 19 0.0010
585 CHOLELITHIASIS 33 0.0010
586 HYPOMAGNESAEMIA 14 0.0010
587 PRODUCTIVE COUGH 48 0.0010
588 APHONIA 14 0.0010
589 ANAL INCONTINENCE 9 0.0010
590 FALL 333 0.0010
591 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 52 0.0010
592 BLOOD TEST ABNORMAL 14 0.0010
593 RASH PRURITIC 54 0.0010
594 HYPERTENSION 211 0.0010
595 NERVE INJURY 11 0.0010
596 INCORRECT PRODUCT STORAGE 13 0.0010
597 MUSCULOSKELETAL DISCOMFORT 17 0.0010
598 EXOSTOSIS 9 0.0010
599 SKIN LESION 27 0.0010
600 DRUG INTOLERANCE 95 0.0010
601 LOSS OF CONSCIOUSNESS 126 0.0010
602 DRUG LEVEL DECREASED 10 0.0010
603 ORAL PAIN 22 0.0010
604 DEPRESSION 223 0.0010
605 NEPHROPATHY TOXIC 11 0.0010
606 ABNORMAL FAECES 8 0.0010
607 DEVICE RELATED INFECTION 15 0.0010
608 EYE INFECTION 11 0.0010
609 THYROID DISORDER 15 0.0010
610 BURNING SENSATION 68 0.0010
611 HYPERSENSITIVITY 180 0.0010
612 PERSONALITY CHANGE 9 0.0010
613 BLADDER CANCER 57 0.0010
614 ERYTHEMA MULTIFORME 9 0.0010
615 PEMPHIGUS 12 0.0010
616 MYOCARDITIS 11 0.0010
617 MUSCULAR WEAKNESS 109 0.0010
618 NERVOUSNESS 50 0.0010
619 DYSPNOEA EXERTIONAL 36 0.0010
620 SWELLING 89 0.0009
621 NEURALGIA 23 0.0009
622 MUSCULOSKELETAL DISORDER 18 0.0009
623 TOOTH DISORDER 21 0.0009
624 HEART RATE DECREASED 33 0.0009
625 COLON CANCER 14 0.0009
626 ABDOMINAL DISTENSION 98 0.0009
627 SWELLING FACE 61 0.0009
628 RESTLESS LEGS SYNDROME 17 0.0009
629 COVID-19 PNEUMONIA 11 0.0009
630 PRESCRIBED OVERDOSE 18 0.0009
631 VITAMIN D DEFICIENCY 9 0.0009
632 HAEMORRHOIDS 18 0.0009
633 HYPOAESTHESIA 138 0.0009
634 ACCIDENT 11 0.0009
635 HEPATOMEGALY 9 0.0009
636 THYROID CANCER 11 0.0009
637 DRUG ADMINISTRATION ERROR 28 0.0009
638 ABDOMINAL PAIN LOWER 23 0.0009
639 PAIN IN EXTREMITY 268 0.0009
640 DRUG LEVEL INCREASED 15 0.0009
641 TENDONITIS 14 0.0009
642 CHEST PAIN 167 0.0009
643 HYPOKINESIA 13 0.0009
644 JOINT SWELLING 108 0.0009
645 BRONCHITIS 66 0.0009
646 ALOPECIA 175 0.0009
647 TENDON RUPTURE 11 0.0009
648 DRUG INTERACTION 141 0.0009
649 VISION BLURRED 122 0.0009
650 MYALGIA 151 0.0009
651 ARRHYTHMIA 42 0.0009
652 HEART RATE IRREGULAR 20 0.0009
653 HEAD INJURY 28 0.0009
654 PNEUMOTHORAX 14 0.0009
655 FEELING HOT 54 0.0009
656 MYOCARDIAL ISCHAEMIA 10 0.0009
657 EAR DISCOMFORT 9 0.0009
658 CHOLECYSTECTOMY 10 0.0009
659 RENAL FAILURE ACUTE 37 0.0009
660 CHOKING 17 0.0009
661 BRAIN OEDEMA 11 0.0009
662 MUSCULOSKELETAL STIFFNESS 76 0.0009
663 INJECTION SITE PRURITUS 58 0.0009
664 INTERVERTEBRAL DISC DEGENERATION 8 0.0009
665 INJECTION SITE IRRITATION 11 0.0009
666 ORAL DISCOMFORT 12 0.0009
667 CONFUSIONAL STATE 139 0.0009
668 KNEE ARTHROPLASTY 18 0.0009
669 DRUG EFFECT INCOMPLETE 31 0.0009
670 AMNESIA 55 0.0008
671 BALANCE DISORDER 73 0.0008
672 DYSPNOEA 478 0.0008
673 BREAST PAIN 9 0.0008
674 AGEUSIA 21 0.0008
675 GAIT DISTURBANCE 161 0.0008
676 ANKLE FRACTURE 13 0.0008
677 HYPERLIPIDAEMIA 10 0.0008
678 MUSCLE RIGIDITY 10 0.0008
679 HEPATIC ENZYME INCREASED 57 0.0008
680 PRURITUS 321 0.0008
681 IMMUNE SYSTEM DISORDER 11 0.0008
682 COUGH 234 0.0008
683 SARS-COV-2 TEST POSITIVE 11 0.0008
684 PARAESTHESIA ORAL 12 0.0008
685 GLAUCOMA 16 0.0008
686 MEDICATION ERROR 46 0.0008
687 INTERVERTEBRAL DISC PROTRUSION 18 0.0008
688 BONE DISORDER 15 0.0008
689 TACHYCARDIA 73 0.0008
690 JOINT RANGE OF MOTION DECREASED 11 0.0008
691 DISCOMFORT 50 0.0008
692 JAUNDICE 22 0.0008
693 INJECTION SITE BRUISING 65 0.0008
694 GASTROINTESTINAL HAEMORRHAGE 68 0.0008
695 LABORATORY TEST ABNORMAL 24 0.0008
696 PSYCHOTIC DISORDER 24 0.0008
697 THINKING ABNORMAL 15 0.0008
698 ILEUS 10 0.0008
699 ARTHRITIS 63 0.0008
700 VISUAL IMPAIRMENT 99 0.0008
701 HYPOAESTHESIA ORAL 12 0.0008
702 JOINT INJURY 17 0.0008
703 OEDEMA 43 0.0008
704 ANGIOEDEMA 35 0.0008
705 SINUSITIS 81 0.0008
706 INFLUENZA LIKE ILLNESS 65 0.0008
707 VENTRICULAR TACHYCARDIA 13 0.0008
708 GENERALISED TONIC-CLONIC SEIZURE 13 0.0008
709 CARDIAC FAILURE CONGESTIVE 63 0.0008
710 DISORIENTATION 31 0.0008
711 NASOPHARYNGITIS 144 0.0008
712 POST PROCEDURAL COMPLICATION 15 0.0008
713 FEAR 21 0.0008
714 LOWER LIMB FRACTURE 15 0.0008
715 INITIAL INSOMNIA 8 0.0008
716 CONTUSION 75 0.0008
717 OSTEOARTHRITIS 33 0.0008
718 FATIGUE 605 0.0008
719 ARTHRALGIA 323 0.0008
720 RHEUMATOID ARTHRITIS 88 0.0008
721 HEADACHE 485 0.0008
722 TOOTHACHE 14 0.0008
723 UPPER GASTROINTESTINAL HAEMORRHAGE 13 0.0008
724 DRUG INEFFECTIVE 1016 0.0008
725 HEMIPARESIS 13 0.0008
726 OROPHARYNGEAL PAIN 71 0.0008
727 HYPONATRAEMIA 43 0.0008
728 HEPATIC FAILURE 23 0.0008
729 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 54 0.0008
730 LIVER FUNCTION TEST ABNORMAL 22 0.0008
731 SUICIDAL IDEATION 69 0.0008
732 WRIST FRACTURE 9 0.0008
733 EPISTAXIS 56 0.0007
734 CARDIAC FAILURE 60 0.0007
735 POOR QUALITY SLEEP 16 0.0007
736 PRODUCT ADMINISTRATION ERROR 15 0.0007
737 COLITIS 28 0.0007
738 PULMONARY MASS 11 0.0007
739 VAGINAL HAEMORRHAGE 32 0.0007
740 BLINDNESS 30 0.0007
741 INFLUENZA 82 0.0007
742 PALLOR 20 0.0007
743 DRUG ERUPTION 13 0.0007
744 LIVER INJURY 18 0.0007
745 PRODUCT USE IN UNAPPROVED INDICATION 181 0.0007
746 WHITE BLOOD CELL COUNT INCREASED 28 0.0007
747 GENERALISED OEDEMA 9 0.0007
748 CORONARY ARTERY DISEASE 22 0.0007
749 SPEECH DISORDER 38 0.0007
750 PARAESTHESIA 114 0.0007
751 DEEP VEIN THROMBOSIS 47 0.0007
752 TREMOR 120 0.0007
753 DIVERTICULITIS 20 0.0007
754 RECTAL HAEMORRHAGE 31 0.0007
755 EAR PAIN 14 0.0007
756 STEVENS-JOHNSON SYNDROME 16 0.0007
757 FEELING COLD 20 0.0007
758 ALANINE AMINOTRANSFERASE INCREASED 44 0.0007
759 PELVIC PAIN 13 0.0007
760 EAR INFECTION 19 0.0007
761 RASH ERYTHEMATOUS 34 0.0007
762 LIMB DISCOMFORT 22 0.0007
763 MUSCULOSKELETAL PAIN 37 0.0007
764 HEPATITIS 18 0.0007
765 INTERNAL HAEMORRHAGE 8 0.0007
766 PAIN 430 0.0007
767 DEPRESSED MOOD 37 0.0007
768 CARDIOGENIC SHOCK 10 0.0007
769 PRODUCT PHYSICAL ISSUE 14 0.0007
770 RESPIRATORY TRACT CONGESTION 11 0.0007
771 PRODUCT QUALITY ISSUE 94 0.0007
772 HAEMATOCHEZIA 38 0.0007
773 FLUID RETENTION 35 0.0007
774 CARDIAC DISORDER 64 0.0007
775 DYSPHONIA 40 0.0007
776 TOOTH INFECTION 9 0.0007
777 THERAPEUTIC RESPONSE DECREASED 41 0.0007
778 CHEST DISCOMFORT 69 0.0007
779 THROMBOSIS 54 0.0007
780 MACULAR DEGENERATION 8 0.0007
781 HEPATIC FUNCTION ABNORMAL 25 0.0007
782 MEMORY IMPAIRMENT 92 0.0007
783 DERMATITIS 14 0.0007
784 DISTURBANCE IN ATTENTION 36 0.0007
785 EXTRA DOSE ADMINISTERED 27 0.0007
786 BLOOD BILIRUBIN INCREASED 18 0.0007
787 IRRITABILITY 40 0.0007
788 NIGHTMARE 23 0.0007
789 MOUTH ULCERATION 14 0.0007
790 INJECTION SITE PAIN 203 0.0007
791 VIRAL INFECTION 22 0.0007
792 ECONOMIC PROBLEM 10 0.0007
793 ANAPHYLACTIC SHOCK 17 0.0007
794 UNRESPONSIVE TO STIMULI 17 0.0007
795 DEVICE FAILURE 10 0.0007
796 VERTIGO 40 0.0007
797 RESPIRATORY TRACT INFECTION 17 0.0007
798 SLEEP DISORDER 46 0.0007
799 PNEUMONIA 211 0.0007
800 MUSCLE TWITCHING 15 0.0007
801 FAECES DISCOLOURED 14 0.0006
802 COORDINATION ABNORMAL 9 0.0006
803 CYST 8 0.0006
804 OSTEONECROSIS 21 0.0006
805 EYE DISORDER 21 0.0006
806 MELAENA 14 0.0006
807 INSOMNIA 169 0.0006
808 THERAPEUTIC RESPONSE SHORTENED 21 0.0006
809 TINNITUS 29 0.0006
810 RASH MACULAR 22 0.0006
811 ACCIDENTAL OVERDOSE 23 0.0006
812 PSORIASIS 82 0.0006
813 COLITIS ULCERATIVE 28 0.0006
814 HOSPITALISATION 96 0.0006
815 INFLAMMATION 32 0.0006
816 NERVOUS SYSTEM DISORDER 19 0.0006
817 NECK PAIN 34 0.0006
818 SKIN HAEMORRHAGE 9 0.0006
819 PSYCHOMOTOR HYPERACTIVITY 10 0.0006
820 PNEUMONIA ASPIRATION 15 0.0006
821 COAGULOPATHY 10 0.0006
822 MULTIPLE ORGAN DYSFUNCTION SYNDROME 17 0.0006
823 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 28 0.0006
824 LYMPHADENOPATHY 21 0.0006
825 TOXIC EPIDERMAL NECROLYSIS 9 0.0006
826 TASTE DISORDER 12 0.0006
827 SOMNOLENCE 119 0.0006
828 HIP FRACTURE 19 0.0006
829 DYSPHAGIA 56 0.0006
830 BACTERIAL INFECTION 11 0.0006
831 TREATMENT FAILURE 48 0.0006
832 VISUAL ACUITY REDUCED 19 0.0006
833 LUNG DISORDER 28 0.0006
834 MOBILITY DECREASED 41 0.0006
835 NEOPLASM MALIGNANT 38 0.0006
836 DEVICE MALFUNCTION 40 0.0006
837 DISSEMINATED INTRAVASCULAR COAGULATION 8 0.0006
838 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 31 0.0006
839 BLOOD ALKALINE PHOSPHATASE INCREASED 14 0.0006
840 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 19 0.0006
841 ANGER 19 0.0006
842 PULMONARY OEDEMA 25 0.0006
843 PULMONARY EMBOLISM 53 0.0006
844 HERPES ZOSTER 32 0.0006
845 SINUS DISORDER 11 0.0006
846 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 100 0.0006
847 APATHY 8 0.0005
848 DELIRIUM 19 0.0005
849 BONE PAIN 32 0.0005
850 COMA 26 0.0005
851 ANAPHYLACTIC REACTION 30 0.0005
852 CARDIOMYOPATHY 8 0.0005
853 HYPOXIA 19 0.0005
854 CONJUNCTIVITIS 10 0.0005
855 DEAFNESS 14 0.0005
856 AGITATION 39 0.0005
857 ERYTHEMA 109 0.0005
858 INJECTION SITE URTICARIA 13 0.0005
859 HYPOCALCAEMIA 10 0.0005
860 PYREXIA 182 0.0005
861 ANXIETY 149 0.0005
862 CHOLESTASIS 10 0.0005
863 CHILLS 61 0.0005
864 HOT FLUSH 39 0.0005
865 INTENTIONAL OVERDOSE 33 0.0005
866 EYE PAIN 29 0.0005
867 IRRITABLE BOWEL SYNDROME 11 0.0005
868 SKIN FISSURES 10 0.0005
869 HEAD DISCOMFORT 9 0.0005
870 EYE PRURITUS 17 0.0005
871 MENTAL STATUS CHANGES 14 0.0005
872 CLOSTRIDIUM DIFFICILE INFECTION 11 0.0005
873 MOOD SWINGS 16 0.0005
874 RESPIRATORY DISORDER 15 0.0005
875 DRUG EFFECT DECREASED 27 0.0005
876 DIPLOPIA 13 0.0005
877 OEDEMA PERIPHERAL 61 0.0005
878 CARDIAC ARREST 41 0.0005
879 COVID-19 87 0.0005
880 HALLUCINATION 37 0.0005
881 RASH PAPULAR 11 0.0005
882 SNEEZING 11 0.0005
883 BRADYCARDIA 26 0.0005
884 ASPARTATE AMINOTRANSFERASE INCREASED 26 0.0005
885 OSTEOPOROSIS 20 0.0005
886 RENAL CANCER 23 0.0005
887 EXPIRED PRODUCT ADMINISTERED 16 0.0005
888 DEVICE ISSUE 43 0.0005
889 GAIT INABILITY 16 0.0005
890 CARDIO-RESPIRATORY ARREST 20 0.0005
891 GASTRIC CANCER 12 0.0005
892 ABNORMAL DREAMS 13 0.0005
893 CIRCULATORY COLLAPSE 8 0.0005
894 THROAT IRRITATION 21 0.0005
895 SKIN CANCER 10 0.0005
896 OCULAR HYPERAEMIA 22 0.0005
897 HAEMATOMA 12 0.0005
898 SKIN EXFOLIATION 39 0.0005
899 CONDITION AGGRAVATED 140 0.0005
900 MENTAL DISORDER 20 0.0005
901 LOCAL SWELLING 8 0.0005
902 JOINT STIFFNESS 12 0.0005
903 DEVICE USE ISSUE 8 0.0005
904 INTERNATIONAL NORMALISED RATIO INCREASED 13 0.0005
905 METASTASES TO LIVER 8 0.0005
906 ABNORMAL BEHAVIOUR 18 0.0005
907 APPLICATION SITE PAIN 10 0.0005
908 INTESTINAL OBSTRUCTION 17 0.0005
909 SEIZURE 52 0.0004
910 PLEURAL EFFUSION 27 0.0004
911 THROAT TIGHTNESS 12 0.0004
912 FLUSHING 45 0.0004
913 LACRIMATION INCREASED 13 0.0004
914 DEPRESSED LEVEL OF CONSCIOUSNESS 17 0.0004
915 STOMATITIS 26 0.0004
916 PRODUCT DOSE OMISSION ISSUE 124 0.0004
917 FEMUR FRACTURE 13 0.0004
918 MIGRAINE 40 0.0004
919 ANHEDONIA 11 0.0004
920 INJECTION SITE SWELLING 32 0.0004
921 HEPATIC CANCER 10 0.0004
922 INJECTION SITE ERYTHEMA 51 0.0004
923 ASCITES 12 0.0004
924 INFUSION RELATED REACTION 27 0.0004
925 ILLNESS 41 0.0004
926 HAEMOPTYSIS 11 0.0004
927 PLATELET COUNT DECREASED 42 0.0004
928 DEMENTIA 11 0.0004
929 INJECTION SITE REACTION 27 0.0004
930 INJECTION SITE RASH 12 0.0004
931 CEREBRAL HAEMORRHAGE 14 0.0004
932 PERICARDIAL EFFUSION 9 0.0004
933 PAIN IN JAW 11 0.0004
934 COGNITIVE DISORDER 18 0.0004
935 ANAEMIA 71 0.0004
936 ALTERED STATE OF CONSCIOUSNESS 8 0.0004
937 MOOD ALTERED 10 0.0004
938 APHASIA 11 0.0004
939 HAEMORRHAGE 38 0.0004
940 PANIC ATTACK 13 0.0004
941 BONE DENSITY DECREASED 11 0.0004
942 INTENTIONAL DOSE OMISSION 10 0.0004
943 DRUG RESISTANCE 9 0.0004
944 RED BLOOD CELL COUNT DECREASED 10 0.0003
945 ILL-DEFINED DISORDER 21 0.0003
946 DYSARTHRIA 13 0.0003
947 ECZEMA 18 0.0003
948 TOXICITY TO VARIOUS AGENTS 57 0.0003
949 CONTRAINDICATED PRODUCT ADMINISTERED 10 0.0003
950 DEVICE DELIVERY SYSTEM ISSUE 9 0.0003
951 SKIN IRRITATION 15 0.0003
952 RESPIRATORY DISTRESS 9 0.0003
953 DRY EYE 16 0.0003
954 GENERAL PHYSICAL HEALTH DETERIORATION 36 0.0003
955 CRYING 11 0.0003
956 HAEMOGLOBIN DECREASED 31 0.0003
957 EMOTIONAL DISTRESS 35 0.0003
958 DEATH 245 0.0003
959 NIGHT SWEATS 9 0.0003
960 ACNE 21 0.0003
961 THERAPY NON-RESPONDER 12 0.0003
962 PRODUCT STORAGE ERROR 23 0.0003
963 DRY SKIN 35 0.0003
964 WITHDRAWAL SYNDROME 11 0.0003
965 EYE IRRITATION 15 0.0003
966 PRODUCT SUBSTITUTION ISSUE 15 0.0003
967 DEVICE USE ERROR 9 0.0003
968 ELECTROCARDIOGRAM QT PROLONGED 9 0.0002
969 PROSTATE CANCER 20 0.0002
970 NEUTROPHIL COUNT DECREASED 10 0.0002
971 LUNG NEOPLASM MALIGNANT 10 0.0002
972 WHITE BLOOD CELL COUNT DECREASED 26 0.0002
973 THERAPY INTERRUPTED 17 0.0002
974 INCORRECT ROUTE OF DRUG ADMINISTRATION 8 0.0002
975 DYSKINESIA 9 0.0002
976 DISEASE RECURRENCE 10 0.0002
977 COMPLETED SUICIDE 17 0.0002
978 MULTIPLE SCLEROSIS 9 0.0002
979 INTERSTITIAL LUNG DISEASE 9 0.0002
980 OVERDOSE 40 0.0002
981 DISEASE PROGRESSION 20 0.0002
982 SKIN BURNING SENSATION 12 0.0002
983 BREAST CANCER 15 0.0002
984 AGGRESSION 8 0.0002
985 MALIGNANT NEOPLASM PROGRESSION 16 0.0002
986 EXPOSURE DURING PREGNANCY 9 0.0001
987 THROMBOCYTOPENIA 16 0.0001
988 ACCIDENTAL EXPOSURE TO PRODUCT 14 0.0001
989 NO ADVERSE EVENT 24 0.0001
990 FOETAL EXPOSURE DURING PREGNANCY 9 0.0001
991 NEUTROPENIA 12 0.0001
992 DRUG DEPENDENCE 8 0.0000